Skip to main content

4 Functional and Nonfunctional Pituitary Adenomas

  • Chapter
  • First Online:
Endoscopic and Keyhole Cranial Base Surgery
  • 816 Accesses

Abstract

Pituitary adenomas are slow-growing, benign tumors that arise from the cells of the pituitary gland. They can be nonfunctional or functional depending on whether they secrete hormones. For non-prolactin-secreting adenomas that are symptomatic through mass effect on local structures or hormonal hypersecretion, or nonfunctional adenomas large enough to warrant elective treatment, surgery is typically recommended. The endoscopic endonasal approach provides safe and thorough exposure of the sella and any tumors within it. Here, we review the process of evaluating patients with pituitary tumors, including the necessary laboratory and radiographic tests for these patients, and the technical aspects of endoscopic endonasal surgery for pituitary tumors, including preoperative considerations, operative technique and nuances, and postoperative complications. In the hands of an experienced neurosurgeon, the endoscopic endonasal technique is quite successful at resecting these common tumors and helping patients improve or maintain their quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97–109.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Scheithauer BW, Gaffey TA, Lloyd RV, Sebo TJ, Kovacs KT, Horvath E, et al. Pathobiology of pituitary adenomas and carcinomas. Neurosurgery. 2006;59(2):341–53; discussion −53.

    Article  PubMed  Google Scholar 

  3. Dolecek TA, Propp JM, Stroup NE, Kruchko C. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro-Oncology. 2012;14(Suppl 5):v1–49.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Shibui S. The present status and trend of brain tumors based on the data of the brain tumor registry of Japan. Brain Nerve. 2012;64(3):286–90.

    PubMed  Google Scholar 

  5. Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, et al. The prevalence of pituitary adenomas: a systematic review. Cancer. 2004;101(3):613–9.

    Article  PubMed  Google Scholar 

  6. Melmed S. Medical progress: acromegaly. N Engl J Med. 2006;355(24):2558–73.

    Article  CAS  PubMed  Google Scholar 

  7. Rogers A, Karavitaki N, Wass JA. Diagnosis and management of prolactinomas and non-functioning pituitary adenomas. BMJ. 2014;349:g5390.

    Article  PubMed  CAS  Google Scholar 

  8. Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(2):273–88.

    Article  CAS  PubMed  Google Scholar 

  9. Greenman Y, Stern N. Non-functioning pituitary adenomas. Best Pract Res Clin Endocrinol Metab. 2009;23(5):625–38.

    Article  CAS  PubMed  Google Scholar 

  10. Jaffe CA. Clinically non-functioning pituitary adenoma. Pituitary. 2006;9(4):317–21.

    Article  PubMed  Google Scholar 

  11. Sharif-Alhoseini M, Laws ER, Rahimi-Movaghar V. Functioning pituitary adenoma. INTECH Open Access Publisher. Croatia. 2012.

    Google Scholar 

  12. Arafah BM, Nasrallah MP. Pituitary tumors: pathophysiology, clinical manifestations and management. Endocr Relat Cancer. 2001;8(4):287–305.

    Article  CAS  PubMed  Google Scholar 

  13. Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A, et al. Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(11):3933–51.

    Article  CAS  PubMed  Google Scholar 

  14. Brabant G. Insulin-like growth factor-I: marker for diagnosis of acromegaly and monitoring the efficacy of treatment. Eur J Endocrinol. 2003;148(Suppl 2):S15–20.

    Article  CAS  PubMed  Google Scholar 

  15. Melmed S, Casanueva FF, Klibanski A, Bronstein MD, Chanson P, Lamberts SW, et al. A consensus on the diagnosis and treatment of acromegaly complications. Pituitary. 2013;16(3):294–302.

    Article  CAS  PubMed  Google Scholar 

  16. Ben-Shlomo A, Melmed S. Acromegaly. Endocrinol Metab Clin N Am. 2008;37(1):101–22. viii

    Article  CAS  Google Scholar 

  17. Scacchi M, Cavagnini F. Acromegaly. Pituitary. 2006;9(4):297–303.

    Article  PubMed  Google Scholar 

  18. Rokkas T, Pistiolas D, Sechopoulos P, Margantinis G, Koukoulis G. Risk of colorectal neoplasm in patients with acromegaly: a meta-analysis. World J Gastroenterol. 2008;14(22):3484–9.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Nganga HK, Lubanga RP. Pituitary macroadenoma presenting with pituitary apoplexy, acromegaly and secondary diabetes mellitus – a case report. Pan Afr Med J. 2013;15:39.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Lindsay JR, Harding JA, Ellis PK, Sheridan B, Atkinson AB. Sustained improvement in vision in a recurrent growth hormone secreting macroadenoma during treatment with octreotide in the absence of marked tumour shrinkage. Pituitary. 2003;6(4):209–14.

    Article  CAS  PubMed  Google Scholar 

  21. Ross EJ, Linch DC. Cushing’s syndrome – killing disease: discriminatory value of signs and symptoms aiding early diagnosis. Lancet. 1982;2(8299):646–9.

    Article  CAS  PubMed  Google Scholar 

  22. Melmed S, Polonsky KS, Larsen PR, Kronenberg H, ClinicalKey Flex. Williams textbook of endocrinology. Philadelphia: Elsevier; 2016. Available from: http://proxy.lib.wayne.edu/login?url=https://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-C20130159806.

  23. Fujimoto N, Saeki N, Miyauchi O, Adachi-Usami E. Criteria for early detection of temporal hemianopia in asymptomatic pituitary tumor. Eye. 2002;16(6):731–8.

    Article  CAS  PubMed  Google Scholar 

  24. Ausman JI. Handbook of neurosurgery, 7(th) edition. Surg Neurol Int. 2010;1:19.

    PubMed Central  Google Scholar 

  25. Verhelst J, Abs R. Hyperprolactinemia: pathophysiology and management. Treat Endocrinol. 2003;2(1):23–32.

    Article  PubMed  Google Scholar 

  26. Ebersold MJ, Quast LM, Laws ER Jr, Scheithauer B, Randall RV. Long-term results in transsphenoidal removal of nonfunctioning pituitary adenomas. J Neurosurg. 1986;64(5):713–9.

    Article  CAS  PubMed  Google Scholar 

  27. Chaudhary V, Bano S. Imaging of the pituitary: recent advances. Indian J Endocrinol Metab. 2011;15(Suppl 3):S216–23.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Fleseriu M, Bodach ME, Tumialan LM, Bonert V, Oyesiku NM, Patil CG, et al. Congress of Neurological Surgeons systematic review and evidence-based guideline for pretreatment endocrine evaluation of patients with nonfunctioning pituitary adenomas. Neurosurgery. 2016;79(4):E527–9.

    Article  PubMed  Google Scholar 

  29. Aflorei ED, Korbonits M. Epidemiology and etiopathogenesis of pituitary adenomas. J Neuro-Oncol. 2014;117(3):379–94.

    Article  Google Scholar 

  30. Jane JA Jr, Laws ER Jr. The management of non-functioning pituitary adenomas. Neurol India. 2003;51(4):461–5.

    PubMed  Google Scholar 

  31. Hemminki K, Forsti A, Ji J. Incidence and familial risks in pituitary adenoma and associated tumors. Endocr Relat Cancer. 2007;14(1):103–9.

    Article  PubMed  Google Scholar 

  32. Ciccarelli A, Daly AF, Beckers A. The epidemiology of prolactinomas. Pituitary. 2005;8(1):3–6.

    Article  PubMed  Google Scholar 

  33. Amlashi FG, Tritos NA. Thyrotropin-secreting pituitary adenomas: epidemiology, diagnosis, and management. Endocrine. 2016;52(3):427–40.

    Article  CAS  PubMed  Google Scholar 

  34. Pecori Giraldi F, Moro M, Cavagnini F, Study Group on the Hypothalamo-Pituitary-Adrenal Axis of the Italian Society of E. Gender-related differences in the presentation and course of Cushing’s disease. J Clin Endocrinol Metab. 2003;88(4):1554–8.

    Article  PubMed  CAS  Google Scholar 

  35. Mindermann T, Wilson CB. Age-related and gender-related occurrence of pituitary adenomas. Clin Endocrinol. 1994;41(3):359–64.

    Article  CAS  Google Scholar 

  36. Casanueva FF, Molitch ME, Schlechte JA, Abs R, Bonert V, Bronstein MD, et al. Guidelines of the pituitary society for the diagnosis and management of prolactinomas. Clin Endocrinol. 2006;65(2):265–73.

    Article  Google Scholar 

  37. Katznelson L, Atkinson JL, Cook DM, Ezzat SZ, Hamrahian AH, Miller KK, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly – 2011 update. Endocr Pract. 2011;17(Suppl 4):1–44.

    Article  PubMed  Google Scholar 

  38. Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF, et al. A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab. 2010;95(7):3141–8.

    Article  CAS  PubMed  Google Scholar 

  39. Hur KY, Kim JH, Kim BJ, Kim MS, Lee EJ, Kim SW. Clinical guidelines for the diagnosis and treatment of Cushing’s disease in Korea. Endocrinol Metab (Seoul). 2015;30(1):7–18.

    Article  CAS  Google Scholar 

  40. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, et al. The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008;93(5):1526–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Elamin MB, Murad MH, Mullan R, Erickson D, Harris K, Nadeem S, et al. Accuracy of diagnostic tests for Cushing’s syndrome: a systematic review and metaanalyses. J Clin Endocrinol Metab. 2008;93(5):1553–62.

    Article  CAS  PubMed  Google Scholar 

  42. Oldfield EH, Chrousos GP, Schulte HM, Schaaf M, McKeever PE, Krudy AG, et al. Preoperative lateralization of ACTH-secreting pituitary microadenomas by bilateral and simultaneous inferior petrosal venous sinus sampling. N Engl J Med. 1985;312(2):100–3.

    Article  CAS  PubMed  Google Scholar 

  43. Doppman JL, Oldfield E, Krudy AG, Chrousos GP, Schulte HM, Schaaf M, et al. Petrosal sinus sampling for Cushing syndrome: anatomical and technical considerations. Work in progress. Radiology. 1984;150(1):99–103.

    Article  CAS  PubMed  Google Scholar 

  44. Alahmadi H, Cusimano MD, Woo K, Mohammed AA, Goguen J, Smyth HS, et al. Impact of technique on cushing disease outcome using strict remission criteria. Can J Neurol Sci. 2013;40(3):334–41.

    Article  PubMed  Google Scholar 

  45. Starke RM, Reames DL, Chen CJ, Laws ER, Jane JA Jr. Endoscopic transsphenoidal surgery for cushing disease: techniques, outcomes, and predictors of remission. Neurosurgery. 2013;72(2):240–7; discussion 7.

    Article  PubMed  Google Scholar 

  46. Biller BM, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, et al. Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab. 2008;93(7):2454–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO, et al. Treatment of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015;100(8):2807–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Bochicchio D, Losa M, Buchfelder M. Factors influencing the immediate and late outcome of Cushing’s disease treated by transsphenoidal surgery: a retrospective study by the European Cushing’s Disease Survey Group. J Clin Endocrinol Metab. 1995;80(11):3114–20.

    CAS  PubMed  Google Scholar 

  49. Atkinson JL, Young WF Jr, Meyer FB, Davis DH, Nippoldt TB, Erickson D, et al. Sublabial transseptal vs transnasal combined endoscopic microsurgery in patients with Cushing disease and MRI-depicted microadenomas. Mayo Clin Proc. 2008;83(5):550–3.

    Article  PubMed  Google Scholar 

  50. Alwani RA, de Herder WW, van Aken MO, van den Berge JH, Delwel EJ, Dallenga AH, et al. Biochemical predictors of outcome of pituitary surgery for Cushing’s disease. Neuroendocrinology. 2010;91(2):169–78.

    Article  CAS  PubMed  Google Scholar 

  51. Acebes JJ, Martino J, Masuet C, Montanya E, Soler J. Early post-operative ACTH and cortisol as predictors of remission in Cushing’s disease. Acta Neurochir. 2007;149(5):471–7; discussion 7-9.

    Article  CAS  PubMed  Google Scholar 

  52. Esposito F, Dusick JR, Cohan P, Moftakhar P, McArthur D, Wang C, et al. Early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing’s disease. J Clin Endocrinol Metabol. 2006;91(1):7–13.

    Article  CAS  Google Scholar 

  53. Tritos NA, Biller BM. Update on radiation therapy in patients with Cushing’s disease. Pituitary. 2015;18(2):263–8.

    Article  CAS  PubMed  Google Scholar 

  54. Chen CC, Carter BS, Wang R, Patel KS, Hess C, Bodach ME, et al. Congress of Neurological Surgeons systematic review and evidence-based guideline on preoperative imaging assessment of patients with suspected nonfunctioning pituitary adenomas. Neurosurgery. 2016;79(4):E524–6.

    Article  PubMed  Google Scholar 

  55. Newman SA, Turbin RE, Bodach ME, Tumialan LM, Oyesiku NM, Litvack Z, et al. Congress of Neurological Surgeons systematic review and evidence-based guideline on pretreatment ophthalmology evaluation in patients with suspected nonfunctioning pituitary adenomas. Neurosurgery. 2016;79(4):E530–2.

    Article  PubMed  Google Scholar 

  56. Kuo JS, Barkhoudarian G, Farrell CJ, Bodach ME, Tumialan LM, Oyesiku NM, et al. Congress of Neurological Surgeons systematic review and evidence-based guideline on surgical techniques and technologies for the management of patients with nonfunctioning pituitary adenomas. Neurosurgery. 2016;79(4):E536–8.

    Article  PubMed  Google Scholar 

  57. Sheehan J, Lee CC, Bodach ME, Tumialan LM, Oyesiku NM, Patil CG, et al. Congress of Neurological Surgeons systematic review and evidence-based guideline for the Management of Patients with Residual or recurrent nonfunctioning pituitary adenomas. Neurosurgery. 2016;79(4):E539–40.

    Article  PubMed  Google Scholar 

  58. Freda PU, Beckers AM, Katznelson L, Molitch ME, Montori VM, Post KD, et al. Pituitary incidentaloma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(4):894–904.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Levy A. Pituitary disease: presentation, diagnosis, and management. J Neurol Neurosurg Psychiatry. 2004;75(Suppl 3):iii47–52.

    PubMed  PubMed Central  Google Scholar 

  60. Rutkowski MJ, Flanigan PM, Aghi MK. Update on the management of recurrent Cushing’s disease. Neurosurg Focus. 2015;38(2):E16.

    Article  PubMed  Google Scholar 

  61. Katavetin P, Cheunsuchon P, Swearingen B, Hedley-Whyte ET, Misra M, Levitsky LL. Review: pituitary adenomas in children and adolescents. J Pediatr Endocrinol Metab. 2010;23(5):427–31.

    Article  PubMed  Google Scholar 

  62. Adelman DT, Liebert KJ, Nachtigall LB, Lamerson M, Bakker B. Acromegaly: the disease, its impact on patients, and managing the burden of long-term treatment. Int J Gen Med. 2013;6:31–8.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Lucas JW, Bodach ME, Tumialan LM, Oyesiku NM, Patil CG, Litvack Z, et al. Congress of Neurological Surgeons systematic review and evidence-based guideline on primary management of patients with nonfunctioning pituitary adenomas. Neurosurgery. 2016;79(4):E533–5.

    Article  PubMed  Google Scholar 

  64. Aghi MK, Chen CC, Fleseriu M, Newman SA, Lucas JW, Kuo JS, et al. Congress of Neurological Surgeons systematic review and evidence-based guidelines on the management of patients with nonfunctioning pituitary adenomas: executive summary. Neurosurgery. 2016;79(4):521–3.

    Article  PubMed  Google Scholar 

  65. Rhoton AL Jr, Hardy DG, Chambers SM. Microsurgical anatomy and dissection of the sphenoid bone, cavernous sinus and sellar region. Surg Neurol. 1979;12(1):63–104.

    PubMed  Google Scholar 

  66. Pait TG, Harris FS, Paullus WS, Rhoton AL Jr. Microsurgical anatomy and dissection of the temporal bone. Surg Neurol. 1977;8(5):363–91.

    CAS  PubMed  Google Scholar 

  67. Rhoton AL Jr, Harris FS, Renn WH. Microsurgical anatomy of the sellar region and cavernous sinus. Clin Neurosurg. 1977;24:54–85.

    Article  PubMed  Google Scholar 

  68. Rhoton AL Jr. The sellar region. Neurosurgery. 2002;51(4 Suppl):S335–74.

    PubMed  Google Scholar 

  69. Inoue T, Rhoton AL Jr, Theele D, Barry ME. Surgical approaches to the cavernous sinus: a microsurgical study. Neurosurgery. 1990;26(6):903–32.

    Article  CAS  PubMed  Google Scholar 

  70. Renn WH, Rhoton AL Jr. Microsurgical anatomy of the sellar region. J Neurosurg. 1975;43(3):288–98.

    Article  CAS  PubMed  Google Scholar 

  71. Thapar K, Kovacs K, Scheithauer B, Lloyd R. Diagnosis and management of pituitary tumors. Philadelphia: Taylor & Francis; 2000.

    Book  Google Scholar 

  72. Gibo H, Lenkey C, Rhoton AL Jr. Microsurgical anatomy of the supraclinoid portion of the internal carotid artery. J Neurosurg. 1981;55(4):560–74.

    Article  CAS  PubMed  Google Scholar 

  73. Gibo H, Carver CC, Rhoton AL Jr, Lenkey C, Mitchell RJ. Microsurgical anatomy of the middle cerebral artery. J Neurosurg. 1981;54(2):151–69.

    Article  CAS  PubMed  Google Scholar 

  74. Saeki N, Rhoton AL Jr. Microsurgical anatomy of the upper basilar artery and the posterior circle of Willis. J Neurosurg. 1977;46(5):563–78.

    Article  CAS  PubMed  Google Scholar 

  75. Perlmutter D, Rhoton AL Jr. Microsurgical anatomy of anterior cerebral anterior communicating recurrent artery complex. Surg Forum. 1976;27(62):464–5.

    CAS  PubMed  Google Scholar 

  76. Hardy DG, Peace DA, Rhoton AL Jr. Microsurgical anatomy of the superior cerebellar artery. Neurosurgery. 1980;6(1):10–28.

    Article  CAS  PubMed  Google Scholar 

  77. Gao Y, Zhong C, Wang Y, Xu S, Guo Y, Dai C, et al. Endoscopic versus microscopic transsphenoidal pituitary adenoma surgery: a meta-analysis. World J Surg Oncol. 2014;12:94.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Ammirati M, Wei L, Ciric I. Short-term outcome of endoscopic versus microscopic pituitary adenoma surgery: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2013;84(8):843–9.

    Article  PubMed  Google Scholar 

  79. Goudakos JK, Markou KD, Georgalas C. Endoscopic versus microscopic trans-sphenoidal pituitary surgery: a systematic review and meta-analysis. Clin Otolaryngol. 2011;36(3):212–20.

    Article  CAS  PubMed  Google Scholar 

  80. Cappabianca P, Cavallo LM, de Divitiis E. Endoscopic endonasal transsphenoidal surgery. Neurosurgery. 2004;55(4):933–40; discussion 40-1.

    Article  PubMed  Google Scholar 

  81. Linsler S, Gaab MR, Oertel J. Endoscopic endonasal transsphenoidal approach to sellar lesions: a detailed account of our mononostril technique. J Neurol Surg B Skull Base. 2013;74(3):146–54.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Tataranu L, Gorgan M, Ciubotaru V, Dediu A, Ene B, Paunescu D, et al. Endoscopic endonasal transsphenoidal approach in the management of sellar and parasellar lesions: indications and standard surgical technique (part I). Rom Neurosurg. 2010;17(1):52–63.

    Google Scholar 

  83. Yadav Y, Sachdev S, Parihar V, Namdev H, Bhatele P. Endoscopic endonasal trans-sphenoid surgery of pituitary adenoma. J Neurosci Rural Pract. 2012;3(3):328–37.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Laws ER, Lanzino G, ClinicalKey Flex. Transsphenoidal surgery. Philadelphia: Saunders; 2010. Available from: http://proxy.lib.wayne.edu/login?url=https://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-C20090320450.

  85. Cappabianca P, Alfieri A, Thermes S, Buonamassa S, de Divitiis E. Instruments for endoscopic endonasal transsphenoidal surgery. Neurosurgery. 1999;45(2):392–5. discussion 5-6

    Article  CAS  PubMed  Google Scholar 

  86. Jho HD, Alfieri A. Endoscopic endonasal pituitary surgery: evolution of surgical technique and equipment in 150 operations. Minim Invasive Neurosurg. 2001;44(1):1–12.

    Article  CAS  PubMed  Google Scholar 

  87. Manara R, Gabrieli J, Citton V, Ceccato F, Rizzati S, Bommarito G, et al. Intracranial internal carotid artery changes in acromegaly: a quantitative magnetic resonance angiography study. Pituitary. 2014;17(5):414–22.

    Article  PubMed  Google Scholar 

  88. Sivakumar W, Chamoun RB, Riva-Cambrin J, Salzman KL, Couldwell WT. Fusiform dilatation of the cavernous carotid artery in acromegalic patients. Acta Neurochir. 2013;155(6):1077–83; discussion 83.

    Article  PubMed  Google Scholar 

  89. Cappabianca P, Cavallo LM, Valente V, Romano I, D’Enza AI, Esposito F, et al. Sellar repair with fibrin sealant and collagen fleece after endoscopic endonasal transsphenoidal surgery. Surg Neurol. 2004;62(3):227–33; discussion 33.

    Article  PubMed  Google Scholar 

  90. Cappabianca P, Cavallo LM, Esposito F, Valente V, De Divitiis E. Sellar repair in endoscopic endonasal transsphenoidal surgery: results of 170 cases. Neurosurgery. 2002;51(6):1365–71; discussion 71-2.

    Article  PubMed  Google Scholar 

  91. de Divitiis E, Spaziante R. Osteoplastic opening of the sellar floor in transsphenoidal surgery: technical note. Neurosurgery. 1987;20(3):445–6.

    Article  PubMed  Google Scholar 

  92. Spaziante R, de Divitiis E, Cappabianca P. Reconstruction of the pituitary fossa in transsphenoidal surgery: an experience of 140 cases. Neurosurgery. 1985;17(3):453–8.

    Article  CAS  PubMed  Google Scholar 

  93. Goel A, Nadkarni T, Muzumdar D, Desai K, Phalke U, Sharma P. Giant pituitary tumors: a study based on surgical treatment of 118 cases. Surg Neurol. 2004;61(5):436–45; discussion 45-6.

    Article  PubMed  Google Scholar 

  94. de Paiva Neto MA, Vandergrift A, Fatemi N, Gorgulho AA, Desalles AA, Cohan P, et al. Endonasal transsphenoidal surgery and multimodality treatment for giant pituitary adenomas. Clin Endocrinol. 2010;72(4):512–9.

    Article  Google Scholar 

  95. Mortini P, Barzaghi R, Losa M, Boari N, Giovanelli M. Surgical treatment of giant pituitary adenomas: strategies and results in a series of 95 consecutive patients. Neurosurgery. 2007;60(6):993–1002; discussion 3-4.

    Article  PubMed  Google Scholar 

  96. Koutourousiou M, Gardner PA, Fernandez-Miranda JC, Paluzzi A, Wang EW, Snyderman CH. Endoscopic endonasal surgery for giant pituitary adenomas: advantages and limitations. J Neurosurg. 2013;118(3):621–31.

    Article  PubMed  Google Scholar 

  97. Wang F, Zhou T, Wei S, Meng X, Zhang J, Hou Y, et al. Endoscopic endonasal transsphenoidal surgery of 1,166 pituitary adenomas. Surg Endosc. 2015;29(6):1270–80.

    Article  PubMed  Google Scholar 

  98. Matsuyama J, Kawase T, Yoshida K, Hasegawa M, Hirose Y, Nagahisa S, et al. Management of large and giant pituitary adenomas with suprasellar extensions. Asian J Neurosurg. 2010;5(1):48–53.

    PubMed  PubMed Central  Google Scholar 

  99. Jho HD, Carrau RL. Endoscopic endonasal transsphenoidal surgery: experience with 50 patients. J Neurosurg. 1997;87(1):44–51.

    Article  CAS  PubMed  Google Scholar 

  100. Theodros D, Patel M, Ruzevick J, Lim M, Bettegowda C. Pituitary adenomas: historical perspective, surgical management and future directions. CNS Oncol. 2015;4(6):411–29.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  101. Ziu M, Dunn IF, Hess C, Fleseriu M, Bodach ME, Tumialan LM, et al. Congress of Neurological Surgeons systematic review and evidence-based guideline on posttreatment follow-up evaluation of patients with nonfunctioning pituitary adenomas. Neurosurgery. 2016;79(4):E541–3.

    Article  PubMed  Google Scholar 

  102. Kreutzer J, Vance ML, Lopes MB, Laws ER Jr. Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria. J Clin Endocrinol Metab. 2001;86(9):4072–7.

    Article  CAS  PubMed  Google Scholar 

  103. Ciric I, Ragin A, Baumgartner C, Pierce D. Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience. Neurosurgery. 1997;40(2):225–36; discussion 36-7.

    Article  CAS  PubMed  Google Scholar 

  104. Cappabianca P, Cavallo LM, Colao A, de Divitiis E. Surgical complications associated with the endoscopic endonasal transsphenoidal approach for pituitary adenomas. J Neurosurg. 2002;97(2):293–8.

    Article  PubMed  Google Scholar 

  105. Barrow DL, Tindall GT. Loss of vision after transsphenoidal surgery. Neurosurgery. 1990;27(1):60–8.

    Article  CAS  PubMed  Google Scholar 

  106. Black PM, Zervas NT, Candia GL. Incidence and management of complications of transsphenoidal operation for pituitary adenomas. Neurosurgery. 1987;20(6):920–4.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Manish K. Aghi .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Chandra, A., Aghi, M.K. (2019). 4 Functional and Nonfunctional Pituitary Adenomas. In: Evans, J., Kenning, T., Farrell, C., Kshettry, V. (eds) Endoscopic and Keyhole Cranial Base Surgery . Springer, Cham. https://doi.org/10.1007/978-3-319-64379-3_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-64379-3_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-64378-6

  • Online ISBN: 978-3-319-64379-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics